ストックスクリーナーアプリを入手
297.89
0.16%
0.49
アフターアワーズ：
300.62
2.73
+0.92%
Amgen Inc (AMGN) 最新ニュース
Should I buy Amgen Inc. (AMG0) stock before earnings seasonPortfolio Update Report & Growth Oriented Trade Recommendations - newser.com
Amgen Inc. $AMGN Shares Acquired by O Keefe Stevens Advisory Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Boston Common Asset Management LLC - MarketBeat
Amgen Inc. $AMGN Stock Position Lifted by Talbot Financial LLC - MarketBeat
Ameriflex Group Inc. Cuts Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Ascent Group LLC - MarketBeat
Ameritas Advisory Services LLC Has $1.23 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(AMGN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
(AMGN) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs - MSN
4 Reasons to Buy Amgen Stock Right Now - sharewise.com
Trading the Move, Not the Narrative: (AMGN) Edition - news.stocktradersdaily.com
AMF Tjanstepension AB Grows Stake in Amgen Inc. $AMGN - MarketBeat
QRG Capital Management Inc. Increases Position in Amgen Inc. $AMGN - MarketBeat
Corundum Group Inc. Grows Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Position Lifted by Precedent Wealth Partners LLC - MarketBeat
Franklin Street Advisors Inc. NC Sells 21,044 Shares of Amgen Inc. $AMGN - MarketBeat
The Technical Signals Behind (AMGN) That Institutions Follow - news.stocktradersdaily.com
Sen. Sheldon Whitehouse Sells Amgen Inc. (NASDAQ:AMGN) Stock - MarketBeat
Amgen (NASDAQ:AMGN) Upgraded to Buy at Wall Street Zen - MarketBeat
(AMGN) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
(AMGN) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Colorado Adopts First State Payment Cap for Amgen’s Enbrel (1) - Bloomberg Law News
Cramer's Stop Trading: Amgen - MSN
How (AMGN) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial - Yahoo Finance
Greenwood Capital Associates LLC Sells 5,673 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Mattern Capital Management LLC - MarketBeat
Hilltop National Bank Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen stock maintains Outperform rating at Oppenheimer after positive Repatha trial - Investing.com
Amgen Inc. $AMGN Stock Position Lifted by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Amgen (AMGN) Is Up 9.7% After Repatha Trial Success and Puerto Rico Expansion Announcement – What's Changed - simplywall.st
Amgen Inc. $AMGN Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Is Amgen Inc. (AMG0) stock a buy for dividend portfoliosJuly 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Amgen Inc. (AMG0) stock extend growth story2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com
Will Amgen Inc. price bounce be sustainable2025 Biggest Moves & Smart Money Movement Tracker - newser.com
Why global investors buy Amgen Inc. (AMG0) stockPortfolio Update Report & Weekly Breakout Opportunity Watchlist - newser.com
What data driven models say about Amgen Inc.’s futureJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com
Short interest data insights for Amgen Inc.Weekly Profit Recap & AI Driven Price Forecasts - newser.com
Primary-Prevention Data Should Boost Uptake Of Amgen’s Repatha - insights.citeline.com
Responsive Playbooks and the AMGN Inflection - news.stocktradersdaily.com
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap - Benzinga
Cartography Bio maps out cancer drug plan with $67 million from Pfizer, Amgen venture units and more - The Business Journals
Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings - FinancialContent
Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise - Yahoo Finance
Amgen claims ‘landmark’ study result that could widen heart drug’s use - BioPharma Dive
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term - sharewise.com
(AMGN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Amgen (AMGN) Hits Key Milestones with Repatha in Cardiovascular Trial - GuruFocus
Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen - The Globe and Mail
Amgen's Repatha Achieves Key Milestones in Phase 3 Cardiovascula - GuruFocus
Amgen’s Repatha reduces cardiovascular events in primary prevention study By Investing.com - Investing.com Canada
First-Ever Primary Prevention Success: Amgen's Repatha Prevents Heart Attacks in 12,000 High-Risk Patients - Stock Titan
Amgen Inc. $AMGN Shares Sold by J. Safra Sarasin Holding AG - MarketBeat
Warren Street Wealth Advisors LLC Has $1.56 Million Position in Amgen Inc. $AMGN - MarketBeat
Consolidated Planning Corp Sells 997 Shares of Amgen Inc. $AMGN - MarketBeat
Hudson Value Partners LLC Grows Position in Amgen Inc. $AMGN - MarketBeat
Lbp Am Sa Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
Price-Driven Insight from (AMGN) for Rule-Based Strategy - news.stocktradersdaily.com
2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer - The Motley Fool
Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion - Yahoo Finance
From Breakthrough Science to Real-World Impact: Amgen's Legacy in Cardiovascular Disease Care - Amgen
Why Are Amgen (AMGN) Shares Soaring Today - The Globe and Mail
Puerto Rico unites its manufacturing center with new expansion and investment from Amgen - The Weekly Journal
Understanding Momentum Shifts in (AMGN) - news.stocktradersdaily.com
Eli Lilly, Amgen among gainers as Pfizer – U.S. drug pricing deal sparks “relief rally” - Seeking Alpha
Amgen, Merck share gains lead Dow's 119-point jump - MSN
Biocon Biologics Gains U.S. Entry for Biosimilars with AMGN Sett - GuruFocus
Understanding the Setup: (AMGN) and Scalable Risk - news.stocktradersdaily.com
Why Amgen Inc. stock is in analyst buy zone2025 Price Targets & Capital Protection Trade Alerts - newser.com
Amgen and Biogen settle patent dispute (AMGN:NASDAQ) - Seeking Alpha
1.07%
0.36%
大文字化:
|
ボリューム (24 時間):